CTOs on the Move

JeNu Biosciences

www.jenu.com

 
JeNu Biosciences was founded by a leading Washington bio scientist and a medical technology entrepreneur. While working on an ultrasound device for topical drug delivery, they became curious about using ultrasound to improve cosmetic skin care product delivery. High energy ultrasound has been proven effective at pushing drugs through the skin, but in the process cells are damaged and high heat causes intense pain. But since cosmetics only need to be absorbed into the top layer of skin rather than through the skin like drugs they thought a low energy ultrasound device might work. After many attempts they proved that ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.jenu.com
  • 1101 N Northlake Way Ste 200
    Seattle, WA USA 98103
  • Phone: 866.565.5368

Executives

Name Title Contact Details

Similar Companies

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

Louisiana Organ Procurement Agency

Louisiana Organ Procurement Agency is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedSynergies

MedSynergies partners with health care organizations and physicians to align their operations by providing revenue cycle management, practice management, consulting services, business process analysis and software integration solutions.

Apria Lifeplus

Apria Lifeplus is a Manchester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SkinCareRx

SkinCareRx is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.